Expert Q&A: Where Medical Affairs is Heading - and How to Keep Up

The next decade promises transformative changes in medical affairs, driven by technological advancements and evolving healthcare needs.

Key trends include the integration of AI and machine learning (ML) for enhanced data analysis and personalised medicine, the rise of digital health technologies like telehealth and remote monitoring, and a growing focus on real-world evidence (RWE) for insights into therapy effectiveness across diverse populations.

These changes call for new expertise in digital health and data, paired with smarter collaboration-to boost decisions, outcomes and efficiency.

Key Questions Answered:

• 1. How do you see AI transforming medical affairs in the next decade?
• 2. What role will digital health technologies play in shaping the future of medical affairs?
• 3. Can you explain the importance of RWE in medical affairs and how it can impact clinical practice and regulatory decisions?
• 4. What challenges do you foresee in integrating AI and ML into medical processes?
• 5. How can medical affairs teams leverage personalised medicine to improve patient outcomes?
• 6. What skills and expertise will be essential for medical affairs professionals to adapt to the rise of digital health technologies?
• 7. How do you anticipate the relationship between medical affairs and other healthcare stakeholders evolving over the next decade?
• 8. What strategies can medical affairs professionals employ to stay ahead of emerging trends and innovations in healthcare?

Methodology:

Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.